HCA Healthcare, Inc.
HCA · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.06 | 2.34 | 0.93 | 0.86 |
| FCF Yield | 3.03% | 3.27% | 0.77% | 1.68% |
| EV / EBITDA | 38.13 | 35.91 | 35.24 | 33.84 |
| Quality | ||||
| ROIC | 4.88% | 4.77% | 4.51% | 4.56% |
| Gross Margin | 15.47% | 15.95% | 15.58% | 15.56% |
| Cash Conversion Ratio | 2.69 | 2.23 | 0.90 | 1.78 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.60% | 5.49% | 5.55% | 5.44% |
| Free Cash Flow Growth | 3.10% | 359.70% | -48.19% | -45.18% |
| Safety | ||||
| Net Debt / EBITDA | 11.63 | 11.81 | 12.15 | 12.31 |
| Interest Coverage | 5.29 | 5.22 | 5.22 | 5.39 |
| Efficiency | ||||
| Inventory Turnover | 9.34 | 8.73 | 8.62 | 8.88 |
| Cash Conversion Cycle | 33.32 | 36.45 | 38.79 | 38.12 |